Welcome to our dedicated page for Titan Acquisition SEC filings (Ticker: TACH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Titan Acquisition's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Titan Acquisition's regulatory disclosures and financial reporting.
Titan Acquisition Corp filed its quarterly report for the period ended September 30, 2025. The SPAC completed its IPO on April 10, 2025, selling 27,600,000 units at $10.00 each for gross proceeds of $276,000,000 and placed $277,380,000 ($10.05 per unit) in a Trust Account.
For Q3 2025, the company reported net income of $2,781,089, driven mainly by an unrealized gain on Trust investments of $2,924,808, against general and administrative expenses of $153,075. Year to date, net income was $5,334,881, including $5,498,221 of unrealized gains. Cash outside the Trust was $859,596, and investments held in the Trust totaled $282,878,221 as of September 30, 2025. Deferred underwriting commissions were $13,140,000.
As of November 13, 2025, the company had 27,600,000 Class A and 6,900,000 Class B ordinary shares outstanding. There were 21,910,056 warrants outstanding (13,800,000 public and 8,110,056 private), each exercisable at $11.50 per share after a business combination. The SPAC has until April 10, 2027 to complete a business combination.